CD36(+)-dendritic epidermal cells: a putative actor in the cutaneous immune system

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Dendritic epidermal cells (DECs) are crucial immune cells in the skin.
• CD36 is a cell surface receptor expressed on various immune cells.
• Understanding DEC subsets is vital for skin immunology research.

Purpose of the Study:

• To investigate the localization, distribution, percentage, and immunological function of CD36(+)-dendritic epidermal cells (CD36(+)-DECs) in normal human skin.
• To determine the role of CD36(+)-DECs in stimulating lymphocyte responses.
• To assess the contribution of CD36(+)-DECs to skin immunity and allograft recognition.

Main Methods:

• Indirect immunofluorescence staining was used to identify and localize CD36(+)-DECs in human skin sections and isolated cells.
• Allogeneic mixed epidermal cell-lymphocyte reaction (ELR) was performed using peripheral blood mononuclear cells (PBMCs) and CD36(+)-DECs.
• Cell proliferation was measured in response to CD36(+)-DECs, with and without Langerhans cells (LCs) and concanavalin A (ConA).

Main Results:

• CD36(+)-DECs were identified in the epidermis, primarily in the basal layer, constituting approximately 2% of epidermal cells.
• These cells were found to be non-adherent and AE3 positive, indicating keratinocyte expression.
• CD36(+)-DECs significantly stimulated allogeneic lymphocyte proliferation, with enhanced effects observed when combined with LCs and ConA.

Conclusions:

• CD36(+)-DECs are present in normal human skin and possess immune-stimulatory properties.
• These cells contribute to the immunological surveillance of the skin.
• CD36(+)-DECs may be involved in the recognition and rejection of cutaneous allografts.